Axumin 1,600 MBq/mL solution for injection, Axumin 3,200 MBq/mL solution for injection, FET clinical trials

Comparison of 18F-Fluciclovine PET versus 18F-Fluoroethyltyrosine PET in patients with newly diagnosed cerebral gliomas, recurrent cerebral gliomas and brain metastases – an open label single centre single arm prospective basket trial

This study compares two types of special body scans (PET scans) for people with brain tumours. It looks at how well these scans show the size and spread of tumours, aiming to see if one scan, Axumin, works as well as or better than another, FET. This could help doctors in the future.